Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Recruiting · NCT06804655 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacoscopy for Patients With Refractory Primary Brain Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, astrocytoma (excluding glioblastoma), central nervous system cancer, ependymoma, epithelial neoplasm, glioblastoma, glioma, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor, tumor of meninges, vascular cancer | Recruiting | Phase 2 | 2026-09-21 | NCT06804655 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cantonal Hospital of St. Gallen | 27 |
| University Hospital, Basel, Switzerland | 243 |
| University Hospital, Zürich | 50 |
| University of Zurich | 188 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cantonal Hospital St Gallen | Sankt Gallen | Switzerland | 2 |
| University Hospital Basel | Basel | Switzerland | 1 |
| University Hospital Zurich | Zurich | Switzerland | 43 |